tiprankstipranks
Klaria Pharma Holding AB (DE:6FN)
FRANKFURT:6FN
Germany Market

Klaria Pharma Holding AB (6FN) Income Statement

Compare
0 Followers

Klaria Pharma Holding AB Income Statement

Last quarter (Q4 2024), Klaria Pharma Holding AB's total revenue was kr1.07M, a decrease of -114.92% from the same quarter last year. In Q4, Klaria Pharma Holding AB's net income was kr-15.58M. See Klaria Pharma Holding AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 2.25Mkr 0.00kr 5.87Mkr 6.11Mkr 7.22M
Gross Profit
kr 2.25Mkr -9.00Kkr 5.87Mkr -4.85Mkr -6.21M
Operating Expenses
kr 33.45Mkr 14.88Mkr 61.31Mkr 80.97Mkr 48.90M
Depreciation and Amortization
kr 11.22Mkr 9.00Kkr 11.03Mkr 10.96Mkr 13.43M
EBITDA
kr -19.99Mkr -14.77Mkr -44.78Mkr -39.41Mkr -35.41M
Operating Income
kr -31.21Mkr -14.68Mkr -54.97Mkr -50.11Mkr -48.74M
Other Income/Expenses
kr -16.52Mkr -3.76Mkr -8.22Mkr -3.44Mkr -2.67M
Pretax Income
kr -47.73Mkr -18.44Mkr -63.66Mkr -53.55Mkr -51.41M
Net Income
kr -47.75Mkr -35.78Mkr -63.77Mkr -53.53Mkr -51.44M
Per Share Metrics
kr ―kr ―kr ―kr ―kr ―
Basic EPS
kr -0.38kr -0.36kr -1.10kr -0.97kr -1.11
Diluted EPS
kr -0.38kr -0.36kr -1.10kr -0.97kr -1.11
Weighted Average Shares Outstanding
124.62M 99.40M 58.10M 55.25M 46.21M
Weighted Average Shares Outstanding (Diluted)
124.62M 100.80M 58.10M 55.25M 46.21M
Currency in SEK

Klaria Pharma Holding AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis